Bentham Science Logo

Track Your Manuscript:


Current Cancer Drug Targets

Volume 20, 11 Issues, 2020
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Cancer Drug Targets, Volume 16 - Number 3


Small Molecules Targeting Ataxia Telangiectasia and Rad3-Related (ATR) Kinase: An Emerging way to Enhance Existing Cancer Therapy

, 16(3): 200 - 208

Martin Andrs, Jan Korabecny, Eugenie Nepovimova, Daniel Jun, Zdenek Hodny and Kamil Kuca


DOI: 10.2174/156800961603160206122927




Potential Therapeutic Approaches for the Treatment of Acute Myeloid Leukemia with AML1-ETO Translocation

, 16(3): 215 - 225

Rashi Arora, Sharad Sawney and Daman Saluja


DOI: 10.2174/1568009616666151113120146



Understanding Cancer Drug Resistance by Developing and Studying Resistant Cell Line Models

, 16(3): 226 - 237

Cristina P.R. Xavier, Milica Pesic and M. Helena Vasconcelos


DOI: 10.2174/1568009616666151113120705



Role of Liprins in the Regulation of Tumor Cell Motility and Invasion

, 16(3): 238 - 248

Sara Chiaretti and Ivan de Curtis


DOI: 10.2174/156800961603160206124103




Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma

, 16(3): 261 - 274

Marilù Fanelli, Claudia Maria Hattinger, Serena Vella, Elisa Tavanti, Francesca Michelacci, Beth Gudeman, Daryl Barnett, Piero Picci and Massimo Serra


DOI: 10.2174/1568009616666151106120434



The Novel VEGF121-VEGF165 Fusion Attenuates Angiogenesis and Drug Resistance via Targeting VEGFR2-HIF-1α-VEGF165/Lon Signaling Through PI3K-AKT-mTOR Pathway

, 16(3): 275 - 286

Jui-Ling Tsai, Yu-May Lee, Chien-Yuan Pan and Alan Yueh-Luen Lee


DOI: 10.2174/156800961603160206125352




Related Journals

Related eBooks

eBooks Catalog